QCOR, KERX Could Break Through Technical Barriers On Improving Fundamentals
Long Ideas - For most mutual funds, tax-loss selling must be done by the end of Monday. As a result, pressure could come off names that have had … Continue Reading
Read NowResearch
A Fresh Look At KERX; High Odds For Zerenex Phase III Success
Long Ideas - Keryx Biopharmaceuticals (NASDAQ:KERX) announced disappointing news earlier this year for its cancer compound perifosine, and the stock remains in the penalty box. However, the story … Continue Reading
Read NowOxford Continues To Cover QCOR’s Acthar, Sales Look Much More Stable Now
Long Ideas - Breaking news that health insurer, Oxford Health, will cover HP Acthar Gel (Acthar), looks like a major win for Questcor Pharmaceuticals (NASDAQ:QCOR), and the stock … Continue Reading
Read NowBorrow On QCOR Shares A Coiled Spring; Stock Could Snap Back Hard
Long Ideas - By now, the bear story on Questcor Pharmaceuticals (NASDAQ:QCOR) is well understood, with health insurer Aetna (NYSE:AET) indicating that it will make it next-to-impossible to … Continue Reading
Read NowPTIE’s Remoxy Remains High On Pfizer’s List of Key Drug Candidates
Long Ideas - Shares of Pain Therapeutics (NASDAQ:PTIE) continue to rise as partner Pfizer (NYSE:PFE) continues to send signals that Remoxy’s New Drug Application (NDA) could be resubmitted … Continue Reading
Read NowNet Positive After QCOR Conference Call; Co. Continues To See Acthar Script Approvals
Research - The 48% decline seen for shares of Questcor Pharmaceuticals (NASDAQ:QCOR) Wednesday prompts the key question of: What to do with the stock now? As a … Continue Reading
Read NowReport: MRGE Could Double As Company Explores Strategic Alternatives
Long Ideas - Merge Healthcare (NASDAQ:MRGE) fell hard earlier this year when the company announced changes to its business model. In particular, the company moved to offer subscription-based … Continue Reading
Read Now